Options Medical Weight Loss Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: people wanting a structured medical weight-loss program with compounded GLP-1 and provider accountability
Options Medical Weight Loss is a solid telehealth option with balanced features and pricing.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Options Medical Weight Loss offers telehealth medical weight-loss programs built around compounded GLP-1 — semaglutide starting around $239/month and tirzepatide from $299/month, plus NAD+ injections at $199/month. GLP-1 is used as one tool within a broader metabolic-health plan with provider support and accountability; programs start at $199/month and are HSA/FSA eligible. It is LegitScript certified, and the brand also runs in-person clinics alongside its online program.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Options Medical Weight Loss
Editorial score · methodology
Breeze Meds
Best for: compounded GLP-1 access with named prescribers and 4-pharmacy network
Editorial score · methodology
Editorial score · methodology
Options Medical Weight Loss at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide from $239, Tirzepatide from $299
- Starting price
- $239/mo (Compounded; programs start at $199/mo, HSA/FSA eligible)
- What's included
- Consult · Shipping · Medication
- FDA status
- No FDA warning letter on record
How we scored Options Medical Weight Loss
Each dimension is scored algorithmically from Options Medical Weight Loss’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.3/10At $239/mo, Options Medical Weight Loss runs about 41% above the $169 median for GLP-1 providers.
Effectiveness25%
8.2/10Options Medical Weight Loss offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.5/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.4/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-09).
Accessibility10%
6.6/10Options Medical Weight Loss's exact state footprint isn't published — confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.0/10Options Medical Weight Loss provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Options Medical Weight Loss review
Last checked July 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with Options Medical Weight Loss
We walked Options Medical Weight Loss’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete an online health intake questionnaire and schedule a secure telehealth video visit.
- 2A provider reviews your history during the video visit and determines whether a GLP-1 is appropriate.
- 3If appropriate, a personalized plan is created and medication is shipped directly to your home with a dosing schedule.
- 4Attend ongoing telehealth visits and messaging for dose adjustments and progress tracking.
- Monthly pricing is shown up front: semaglutide injections from $199/mo, tirzepatide from $299/mo, oral semaglutide from $239/mo, oral tirzepatide from $339/mo.
- An initial telehealth video visit is explicitly required as part of intake.
- Labs/metabolic analysis are mentioned as a program component but no explicit requirement or frequency is stated.
- A refund form link exists but refund terms, cancellation terms, and shipping timelines/costs are not detailed.
- Only a phone number is provided; support hours are not stated.
Options Medical Weight Loss customer support
- Phone
- 888-405-5673
GLP-1 medications Options Medical Weight Loss offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Compounded; programs start at $199/mo, HSA/FSA eligible
Compounded; higher tiers $339-$399/mo
Ready to get started?
Plans and promotions change often — check Options Medical Weight Loss's current pricing and active discounts before you decide.
What we like
- LegitScript certified with clear, upfront program pricing
- Compounded semaglutide (~$239) and tirzepatide (from $299), plus NAD+
- Structured metabolic-health program with provider support and accountability
- HSA/FSA eligible with flexible payment options
Watch-outs
- Doesn't clearly publish which states its telehealth covers
- Tirzepatide tiers climb to $339-$399/month
- More program structure (and cost) than medication-only sellers
- Compounded GLP-1 only online — no brand-name options noted
Is Options Medical Weight Loss worth it? Our verdict
Options Medical Weight Loss positions itself around one thing: people wanting a structured medical weight-loss program with compounded GLP-1 and provider accountability. It runs $239/month — a premium to the category, so the extras need to justify it.
On top of the prescription itself, Options Medical Weight Loss points to Telehealth medical weight loss, Compounded GLP-1, and LegitScript Certified.
How much Options Medical Weight Loss actually costs
- semaglutide — $239/month
- tirzepatide — $299/month
For context, the typical ongoing price across the GLP-1 providers we track is around $169/month, so Options Medical Weight Loss's standing rate sits at the premium end.
For a direct comparison, MadeMed runs semaglutide and tirzepatide from $219/month — worth pricing against Options Medical Weight Loss before you commit.
Medications: what Options Medical Weight Loss prescribes
Options Medical Weight Loss prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes.
Who Options Medical Weight Loss is best for — and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like bmiMD will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. We explain how we weigh medical oversight and compliance in our scoring methodology.
Bottom line
Options Medical Weight Loss costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, Wellorithm is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Options Medical Weight Loss is a solid telehealth option with balanced features and pricing.
Ready to start with Options Medical Weight Loss?
Starting at $239/month. See current pricing and start your free consultation.
Options Medical Weight Loss might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Options Medical Weight Loss review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Options Medical Weight Loss's current pricing
Plans start at $239/month. Start your free consultation to check eligibility and today's price.